Bahrain vs Small island developing States (SIDS): Percentage of bloodstream infection due to Escherichia coli resistant
Bahrain
63.0%
in 2022
Small island developing States (SIDS)
50.0%
in 2022
Bahrain rank
9th
Small island developing States (SIDS) rank
8th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Bahrain
- Small island developing States (SIDS)
How they compare
Bahrain currently reports 63.0% against 50.0% in Small island developing States (SIDS), a difference of 13.0%.
That makes Bahrain's figure about 1.3 times Small island developing States (SIDS)'s.
The two have swapped places 1 time across 5 shared years of data; in 2018 it was Small island developing States (SIDS) ahead.
Bahrain ranks 9th and Small island developing States (SIDS) ranks 8th of 50 countries.
Bahrain has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.5% | 45.9% | 2.7% | Bahrain |
| 2020s | 59.9% | 43.4% | 16.5% | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Bahrain or Small island developing States (SIDS)?
- Bahrain, at 63.0% against 50.0% in Small island developing States (SIDS) as of 2022.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Bahrain and Small island developing States (SIDS)?
- 13.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Small island developing States (SIDS)?
- 5 years are reported by both, from 2018 to 2022.
- How do Bahrain and Small island developing States (SIDS) rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Bahrain ranks 9th and Small island developing States (SIDS) ranks 8th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.